Filing Details
- Accession Number:
- 0001179110-20-005089
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-24 16:13:41
- Reporting Period:
- 2020-04-22
- Accepted Time:
- 2020-04-24 16:13:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1709401 | Rubius Therapeutics Inc. | RUBY | Biological Products, (No Disgnostic Substances) (2836) | 042688109 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1799032 | M. Christina Coughlin | C/O Rubius Therapeutics, Inc. 399 Binney Street, Suite 300 Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-22 | 19,000 | $5.52 | 19,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
